These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 20159883)

  • 41. Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis.
    Piovezan JM; Premaor MO; Comim FV
    Hum Reprod Update; 2019 Sep; 25(5):633-645. PubMed ID: 31374576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analysis of disturbances in carbohydrate metabolism in the adult population of Yecla (Murcia, Spain)].
    Martínez Candela J; Gallardo Martín A; Franch Nadal J; Romero Ortiz J; Cánovas Domínguez C; Gómez Marco R
    Aten Primaria; 2004 Oct; 34(7):345-52. PubMed ID: 15511355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome.
    Sawada M; Masuyama H; Hayata K; Kamada Y; Nakamura K; Hiramatsu Y
    Endocr J; 2015; 62(11):1017-23. PubMed ID: 26370557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pregnancy outcomes after laparoscopic ovarian drilling in women with polycystic ovarian syndrome.
    Al-Ojaimi EH
    Saudi Med J; 2006 Apr; 27(4):519-25. PubMed ID: 16598331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of metabolic syndrome among Iranian women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Niksima SH; Odel NM; Khaki S; Ghanei Gheshlagh R; Fallahi A; Kurdi A
    Diabetes Metab Syndr; 2019; 13(3):1911-1915. PubMed ID: 31235114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.
    Legro RS; Gnatuk CL; Kunselman AR; Dunaif A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3236-42. PubMed ID: 15797965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome.
    Joham AE; Ranasinha S; Zoungas S; Moran L; Teede HJ
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E447-52. PubMed ID: 24081730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: A systematic review and meta-analysis.
    Khorshidi A; Azami M; Tardeh S; Tardeh Z
    Diabetes Metab Syndr; 2019; 13(4):2747-2753. PubMed ID: 31405703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus.
    Capula C; Chiefari E; Vero A; Foti DP; Brunetti A; Vero R
    Diabetes Res Clin Pract; 2014 Aug; 105(2):223-30. PubMed ID: 24931701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
    Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
    Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative evaluation of waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index as indicators of impaired glucose tolerance and as risk factors for type-2 diabetes mellitus.
    Łopatyński J; Mardarowicz G; Szcześniak G
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):413-9. PubMed ID: 15315025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting adult metabolic syndrome from childhood body mass index: follow-up of the New Delhi birth cohort.
    Sachdev HP; Osmond C; Fall CH; Lakshmy R; Ramji S; Dey Biswas SK; Prabhakaran D; Tandon N; Reddy KS; Barker DJ; Bhargava SK
    Arch Dis Child; 2009 Oct; 94(10):768-74. PubMed ID: 19015213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.
    Sirmans SM; Parish RC; Blake S; Wang X
    J Investig Med; 2014 Aug; 62(6):868-74. PubMed ID: 24844662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of metabolic syndrome in adolescents with polycystic ovarian syndrome: A systematic review and meta-analysis.
    Fazleen NE; Whittaker M; Mamun A
    Diabetes Metab Syndr; 2018 Nov; 12(6):1083-1090. PubMed ID: 29789222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome.
    Palomba S; Falbo A; Russo T; Rivoli L; Orio M; Cosco AG; Vero R; Capula C; Tolino A; Zullo F; Colao A; Orio F
    Diabetes Care; 2012 Apr; 35(4):861-7. PubMed ID: 22338097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Characteristics of glucose metabolism in non-obese and obese women with polycystic ovarian syndrome].
    Shi YH; Zhao DN; Zhao JL; You L; Liu H; Sun M; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):575-7. PubMed ID: 21029611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome.
    Möhlig M; Weickert MO; Ghadamgahi E; Arafat AM; Spranger J; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2008 Apr; 158(4):517-23. PubMed ID: 18362299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucose intolerance states in women with the polycystic ovary syndrome.
    Pasquali R; Gambineri A
    J Endocrinol Invest; 2013 Sep; 36(8):648-53. PubMed ID: 24105073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.